Abstract:Many bioactivities of hydrolysates from oyster (Crassostrea gigas) muscle have been reported, while there is no knowledge about its protective effects on alcohol-induced liver disease (ALD). In the present study, the anti-oxidative activities in vitro and molecular weight distribution of oyster hydrolysates (OPHs) were detected and OPHs released by alcalase (AOPH) were used to treat C57BL/6 mice. The content of small-weight components (< 2.0 kDa) of OPHs reached 90.85%. Compared to model mice, oral administration (4 weeks) of AOPHs at 800 mg/kg body weight could ease up a decline in T-AOC, GSH-PX, and ADH. The hepatocellular lesions were effectively relieved and impaired liver tissue development was successfully inhibited. Total 834 genes and 54 proteins showed differential expression in the AOPH group and the oxidative metabolites of ethanol such as oxidative phosphorylation, glutathione metabolism, peroxisome, PPAR signaling pathway, drug metabolism-cytochrome P450, which play a preeminent role in ALD according to results of transcriptomics and proteomics. The beneficial effects of AOPHs were available in the improvement of ALD. These results revealed that AOPHs intervention ameliorated ALD by affecting oxidative metabolism and highlighting AOPHs potential application as a functional food.

Protective effects of oyster protein hydrolysates on alcohol-induced liver disease (ALD) in mice: Based on the mechanism of anti-oxidative metabolism